Login to Your Account

NewCo News: BeiGene Banking on China's Cancer Network, Pharma

By Tom Wall

Monday, May 2, 2011
Not yet a year old, Beijing-based start-up BeiGene Ltd. entered an agreement with Merck & Co. Inc., which will provide unspecified debt and equity financing to help support BeiGene's preclinical discovery, cancer biomarker research and clinical-stage oncology candidate development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription